Joel Litman High Alpha Strategic Acquirers in the Health Care Space

Get Joel Litman and Doc Eifrig’s list of favorite health care stocks. These are companies with ample cash flow and the financial muscle to make smart acquisitions as 1 in 3 U.S. companies collide into a Wall of Debt.

Joel Litman High Alpha Strategic Acquirers in the Health Care Space Exposed

According to Joel Litman, there’s a huge opportunity in strategic acquirers right now.

The Federal Reserve is committed to keeping rates high while it combats inflation. Smaller companies are suffering from challenging debt loads they can’t easily refinance.

With no cash… and government-extended credit running out… they’re facing some tough choices to stay afloat.

Many of these businesses will have to start shedding assets, whether they like it or not. And great strategic acquirers will scoop up those deals at a discount… positioning themselves for years of growth.

Joel Litman is not the only one who has noticed a huge opportunity in strategic acquirers. He recently teamed up with Dr. David “Doc” Eifrig – a senior partner at Stansberry Research – to reveal why this setup could be the most overlooked stock market opportunity of 2024.

In their brand-new interview, they share all the details of the well-hidden crisis that’s hitting a third of U.S. companies… and how it could lead to 500% upside in a select corner of the market. Plus, Joel Litman and Doc Eifrig “sound the alarm” on 18 widely owned stocks you should sell immediatelyClick here for the full story.

Bad Omen for 1 in 3 U.S. Stocks?

We’re only 45 days into the year…

And already, Joel Litman says that he’s worried about how much optimism he sees in the stock market right now.

Because his system sees a completely different picture…

In fact, it’s flashing a disturbing pattern for 1 in 3 U.S. stocks.

Some of the world’s biggest and most widely owned businesses are in trouble.

And even if you don’t own shares of them, this developing situation could have huge consequences for you.

That’s why Joel Litman just stepped forward with new recommendations for your money.

Joel says that no one is covering this urgent financial story…

Nor the tremendous, well-hidden opportunity this crisis presents to make a windfall.

This situation is also why – for the first time ever – Joel Litman invited a special guest to join him and provide the exact game plan for the rest of 2024, right here.

He’s a Wall Street insider and agrees that what’s unfolding could make history.

Click here to get the full details.

In short: There is an escalating financial trend that could send 1 in 3 U.S. stocks crashing… and your portfolio is likely at risk.

This is NOT some pie-in-the-sky prediction.

It’s grounded in the same set of proprietary data Joel Litman used to predict the 2008, 2020, and 2022 crashes… as well as the collapse of over 40 different companies since 2020.

As always, his goal is to make sure you’re prepared for what’s ahead.

Here’s what you need to know.

Joel Litman and Doc Eifrig reveal “The Most Bullish Setup for 2024.”

Two Wall Street veterans recently revealed what they say is “The Most Bullish Setup for 2024.”

It’s not AI, tech, or anything you’ve ever likely considered.

Instead, it’s part of a phenomenon impacting 1 in 3 U.S. stocks right now – a situation most investors are missing.

I happen to know these titans personally…

  • One recommended chipmaker Advanced Micro Devices (AMD) at $2.67 (before it rose over 6,300%)… and foresaw the 2020 market rebound, recommending TWENTY stocks that soared triple-digit gains.
  • And the other has maintained a 94% win rate for his readers since 2010… a remarkable achievement for any investor.

I’ll be watching their most recent interview, and recommend you do the same.

I haven’t heard or read a single analyst make a similar prediction with the supporting data they have…

And it’s only a matter of time before the masses catch on.

Get the full story here.

When you tune in, you’ll also receive a free recommendation

Get the name and ticker here.


You may also like these posts...

What Is Stansberry's Company To Dominate The Health Market With A Weight-Loss Treatment?

What Is Stansberry’s Company To Dominate The Health Market With A Weight-Loss Treatment?

A big story in health care is set to play out in the coming years. Dr. David Eifrig and Thomas Carroll – editor and senior analyst, respectively, of Prosperity Investor – are joining forces today to explain why.
Jeff Clark's 3-Stock Retirement Blueprint - Get Names And Tickers

Jeff Clark’s 3-Stock Retirement Blueprint: Get Names And Tickers

Jeff Clark is ready to reveal the exact blueprint - The 3-Stock Retirement Blueprint - for how this bull market ends — and what you can do right now to prepare. Plus, he’s also giving away the name and ticker of the #1 stock you’ll want to start trading today.